Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: Involvement of intestinal epithelial costimulatory molecules

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Miyauchi, Eiji ^a,b   Ogita, Tasuku ^a   Miyamoto, Junki ^a   Kawamoto, Seiji ^a   Morita, Hidetoshi ^c   Ohno, Hiroshi ^b   Suzuki, Takuya ^a   Tanabe, Soichi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c AZABU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 17; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM LONGUM; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG MECHANISM; FEMALE; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BIFIDOBACTERIUM; COLITIS; CYTOKINES; DEXTRAN SULFATE; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-17; INTESTINAL MUCOSA; MICE; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84892531568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079735     Document Type: Article

References (43)

1. Abraham C, Medzhitov R (2011) Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140: 1729-1737. doi:10.1053/j.gastro.2011.02.012. PubMed: 21530739.
2. Hershberg RM, Mayer LF (2000) Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 21: 123-128. doi:10.1016/S0167-5699(99)01575-3. PubMed: 10689299.
3. Westendorf AM, Fleissner D, Groebe L, Jung S, Gruber AD et al. (2009) CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells. Gut 58: 211-219. doi:10.1136/gut.2008.151720. PubMed: 18832523.
4. Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M et al. (2007) Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 292: G1630-G1640. doi:10.1152/ajpgi.00294.2006. PubMed: 17347451.
5. Borcherding F, Nitschke M, Hundorfean G, Rupp J, von Smolinski D et al. (2010) The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol 176: 1816-1827. doi:10.2353/ajpath. 2010.090461. PubMed: 20133813.
6. Nakazawa A, Dotan I, Brimnes J, Allez M, Shao L et al. (2004) The expression and function of costimulatory molecules B7h and B7-H1 on colonic epithelial cells. Gastroenterology 126: 1347-1357. doi:10.1053/j.gastro.2004.02. 004. PubMed: 15131796.
7. Olsen T, Rismo R, Cui G, Goll R, Christiansen I et al. (2011) TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine 56: 633-640. doi:10.1016/j.cyto.2011.08.036. PubMed: 21945121.
8. Verdier J, Begue B, Cerf-Bensussan N, Ruemmele FM (2012) Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases. Inflamm Bowel Dis, 18: 1260-6. PubMed: 21994045.
9. Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR et al. (2008) A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 135: 1130-1141. doi:10.1053/j.gastro. 2008.07.014. PubMed: 18706417.
10. Melgar S, Karlsson L, Rehnström E, Karlsson A, Utkovic H et al. (2008) Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol 8: 836-844. doi:10.1016/j.intimp.2008.01.036. PubMed: 18442787.
11. Fitzpatrick LR, Deml L, Hofmann C, Small JS, Groeppel M et al. (2010) 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease. Inflamm Bowel Dis 16: 1763-1777. doi:10.1002/ibd.21264. PubMed: 20310011.
12. Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY et al. (2006) A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis 12: 558-565. doi:10.1097/01.ibd.0000225337.14356.31. PubMed: 16804392.
13. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A et al. (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 377: 12-16. doi:10.1016/j.bbrc.2008.09.019. PubMed: 18796297.
14. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317. doi:10.1038/nature10209. PubMed: 21677747.
15. Prisciandaro L, Geier M, Butler R, Cummins A, Howarth G (2009) Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 15: 1906-1914. doi:10.1002/ibd.20938. PubMed: 19373788.
16. Miyauchi E, Morita H, Tanabe S (2009) Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 92: 2400-2408. doi:10.3168/jds.2008-1698. PubMed: 19447972.
17. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P et al. (2009) Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gdT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 15: 1526-1536. doi:10.1002/ibd.20961. PubMed: 19504616.
18. Fernandez EM, Valenti V, Rockel C (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1444-1444. doi:10.1136/gut.2010.230292corr1. PubMed: 21335567.
19. Ogita T, Nakashima M, Morita H, Saito Y, Suzuki T et al. (2011) Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells. J Biomed Biotechnol: 2011: 378417. PubMed: 22013382
20. Resta-Lenert S, Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997. doi:10.1136/gut.52.7.988. PubMed: 12801956.
21. Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K et al. (2011) Heat-killed body of Lactobacillus brevis sbc8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis 17: 2235-2250. doi:10.1002/ibd.21597. PubMed: 21987297.
22. Tanabe S, Kinuta Y, Saito Y (2008) Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 22: 181-185. PubMed: 18636171.
23. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE et al. (2009) Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 15: 341-352. doi: 10.1002/ibd.20753. PubMed: 18942757.
24. Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R et al. (2008) Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 134: 1038-1048. doi:10.1053/j.gastro. 2008.01.041. PubMed: 18395085.
25. Telega GW, Baumgart DC, Carding SR (2000) Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states. Gastroenterology 119: 1548-1559. doi: 10.1053/gast.2000.20168. PubMed: 11113076.
26. Cruickshank SM, McVay LD, Baumgart DC, Felsburg PJ, Carding SR (2004) Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut 53: 678-684. doi:10.1136/gut.2003.029967. PubMed: 15082586.
27. Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ et al. (2009) CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci U S A 106: 876-881. doi:10.1073/pnas.0810769106. PubMed: 19136631.
28. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234. doi:10.1038/nature04754. PubMed: 16648837.
29. Shaw MH, Kamada N, Kim YG, Núñez G (2012) Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 209: 251-258. doi:10.1084/jem.20111703. PubMed: 22291094.
30. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC et al. (1994) Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 152: 5643-5652. PubMed: 7515910.
31. Shin T, Kennedy G, Gorski K, Tsuchiya H, Koseki H et al. (2003) Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4(+) T cells independent of the PD-1 receptor. J Exp Med 198: 31-38. doi: 10.1084/jem.20030242. PubMed: 12847135.
32. Ghadimi D, de Vrese M, Heller KJ, Schrezenmeir J (2010) Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflamm Bowel Dis 16: 410-427. doi:10.1002/ibd.21057. PubMed: 19714766.
33. Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI et al. (2012) Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol Immunol 56: 27-39. doi: 10.1111/j.1348-0421.2011.00398.x. PubMed: 22040047.
34. Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N et al. (2009) Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLOS ONE 4: e5184. doi: 10.1371/journal.pone.0005184. PubMed: 19381276.
35. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A et al. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-G1034. doi:10.1152/ajpgi.90227.2008. PubMed: 18787064.
36. Singh N, Arioli S, Wang A, Villa CR, Jahani R et al. (2013) Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms. FEMS Microbiol Ecol (. (2013)) PubMed: 23551062.
37. Wall R, Marques TM, O'Sullivan O, Ross RP, Shanahan F et al. (2012) Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 95: 1278-1287. doi: 10.3945/ajcn.111.026435. PubMed: 22492373.
38. Odamaki T, Sugahara H, Yonezawa S, Yaeshima T, Iwatsuki K et al. (2012) Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe 18: 14-18. doi:10.1016/j.anaerobe. 2011.11.004. PubMed: 22138361.
39. Tanabe S (2013) The effect of probiotics and gut microbiota on Th17 cells. Int Rev Immunol (. (2013)) PubMed: 24094077.
40. Azuma YT, Hagi K, Shintani N, Kuwamura M, Nakajima H et al. (2008) PACAP provides colonic protection against dextran sodium sulfate induced colitis. J Cell Physiol 216: 111-119. doi:10.1002/jcp.21381. PubMed: 18205183.
41. Mattson MP, Barger SW, Begley JG, Mark RJ (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol 46: 187-216. doi:10.1016/S0091-679X(08)61930-5. PubMed: 7541884.
42. Tsuruo T, Yamori T, Naganuma K, Tsukagoshi S, Sakurai Y (1983) Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res 43: 5437-5442. PubMed: 6616476.
43. -ΔΔCT method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.